🔥 Thrive Just Raised $2 Billion to Buy Boring Companies — Then Rewire Them With AI

OpenAI-backed Thrive Holdings raised $2B at a $12B valuation to buy accounting and IT firms and rewire them with AI.

› Read article By Jen-Yu Teng

Lenovo

🔥 Lenovo Just Posted Its Biggest Quarter Ever — and Still Booked a $609 Million Loss

Lenovo posted a record $26.94B quarter, up 43% on booming AI server demand — but a $1.69B non-cash warrant charge flipped it to a $609M reported loss.

Today's Picks

🔥 The AI Coding Startup That Wants to Be Worth $40 Billion — 90 Days After It Was Worth $26 Billion

Aug 13, 2026 · 4 min read

Startups

🔥 Whatnot Just Hit a $20 Billion Valuation Selling You Trading Cards on Livestream — With Almost No AI Pitch

Aug 12, 2026 · 4 min read

Robotics

🔥 Two Former Teenage Drone Racers Just Raised $250 Million to Build a Million Drones a Year

Aug 12, 2026 · 4 min read

Biotech

🔥 Jazz Just Paid $820 Million for an Epilepsy Drug Still Stuck in Phase 1 — and It's Meant for 2,500 People

Aug 11, 2026 · 4 min read

Latest

Autonomous Vehicles

🔥 Uber Is Spending $10 Billion on Robotaxis — and It Won't Build a Single One

Uber pledged more than $10 billion to autonomous vehicles and a goal of 120,000 driverless cars on its network — without building a single one. Inside the bet to own the app, not the car.

Fintech

🔥 Palmer Luckey's Bank Quadrupled Its Deposits in a Quarter — Now It's Raising $1.5 Billion at an $8 Billion Valuation

Erebor, Palmer Luckey's crypto-friendly startup bank, nearly quadrupled deposits to $4.05B in a quarter and is raising $1.5B at an $8B valuation. The SVB-shaped hole, filled fast.

Energy

🔥 Michael Dell's Son Built a $13 Billion Battery Company by Renting Out Your Backyard

Base Power raised $1B at a $13B valuation to bury US-made batteries in Texas backyards and run them as one giant virtual power plant.

AI See all →

🔥 Socure Grabbed $156 Million, Bought an AI Fraud Squad, and Hit a $5.2 Billion Valuation

Socure raised $156M at a $5.2B valuation and bought agentic-AI startup Fravity to fight machine-speed fraud with AI agents of its own.

🔥 Hugging Face Is Selling a $399 Robot Duck That Teaches Itself to Walk. The Cheapest Humanoid Costs $13,500.

Aug 30, 2026 · 4 min read

🔥 Software Ate the World. Now a16z Is Betting $1.1 Billion on the Machines Underneath.

Aug 29, 2026 · 4 min read

🔥 Google Promised Marvell $120 Billion in Chips. The Stock Fell 7% the Day It Beat Earnings.

Aug 28, 2026 · 4 min read

Hardware See all →

Gigabyte Just Dropped a WOLED Gaming Monitor and It Changes Everything

🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...

Cerebras Surges 68% in Record-Breaking IPO: What It Means for the AI...

The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...

The Lean Startup AI Stack: 7 Tools That Ship Products in 2026

> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...

Software See all →

The Ultimate Guide to Developer Documentation

May 16, 2026 · 4 min read

Gigabyte Just Dropped a WOLED Gaming Monitor and It Changes Everything

May 16, 2026 · 4 min read

Cerebras Surges 68% in Record-Breaking IPO: What It Means for the AI...

May 16, 2026 · 5 min read

🔥 Airtable Was Worth $11.7 Billion. Bending Spoons Just Bought It for $1.285 Billion.

Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.

Biotech See all →

🔥 A Pill Just Doubled Survival in Pancreatic Cancer. The FDA Cleared It in About a Month — at $477,000 a Year.

The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.

🔥 Ultragenyx's First Gene Therapy Costs $2.7 Million. It Buys GSDIa Patients Freedom From the Cornstarch Clock.

The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.

🔥 AusperBio Raised $120 Million on a Hepatitis B Drug That Cleared the Virus in 68% of a Small Trial

AusperBio raised $120M to push AHB-137, an antisense drug that cleared hepatitis B in 68% of a small trial, toward the first functional cure for a disease 240 million people live with.